After treatment with GM6001, a general MMP inhibitor, invasive activity was reduced by similar levels in mock-transfected cells and those transfected with mDia1-CA (Figure 2A), indicating the involvement of MMP activity in mDia1-mediated cancer cell invasion. This evidence concerns the gene DIAPH1 and cancer.